Melinda French warns that limiting mifepristone access raises health risks for U.S. women

Melinda French warns that limiting mifepristone access raises health risks for U.S. women
Melinda French on mifepristone access

Mifepristone, a medication commonly used for medical abortions, is described by Melinda French as essential for women navigating some of their most difficult decisions.

In a recent statement on social media, French explained that reducing access to mifepristone does not eliminate the need for such care. Rather, it increases the challenges and risks for individuals seeking it. The ongoing policy debate in the U.S. over reproductive health access has kept mifepristone in the national spotlight, as stakeholders consider the medical, ethical, and legal implications of limiting its availability.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.